Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Merck Canada applauds initiative to improve access to over the counter medicines for Canadians

May 1, 2012

KIRKLAND, QC, May 1, 2012 /CNW Telbec/ – Merck Canada supports Health
Canada’s initiative to ensure Canadians have quicker access to products
that are switched from prescription to over-the-counter (OTC)
medicines. On Thursday, April 26(th), the Federal Government announced that, as part of the Economic Action
Plan 2012, it will eliminate regulatory red tape that currently delays
the availability of medicines as over-the-counter (OTC) drugs.

“As a healthcare company, we realize that there are many components to a
healthy society. Providing consumers with more OTC healthcare
alternatives is a great way to promote the importance of self-care
within our society and contribute to the viability of our health care
system” said Mr. Bruno Mäder, General Manager, Merck Consumer Care “We
applaud all measures that will make our healthcare system more
efficient without compromising the health and safety of consumers”.

The Federal Government announcement indicated that that they will reduce
the delays associated with switching a drug from prescription status to
OTC status by eliminating Schedule F of Health Canada’s Food and Drug
Regulations. Drug safety will continue to be confirmed through the same
rigorous process of scientific review before a drug can be approved for
sale and before a drug can be sold OTC.

About Merck

Today’s Merck is a global healthcare leader working to help the world be
well.  Merck is known as MSD outside the United States and Canada.
Through our prescription medicines, vaccines, biologic therapies, and
consumer care and animal health products, we work with customers and
operate in more than 140 countries to deliver innovative health
solutions. We also demonstrate our commitment to increasing access to
healthcare through far-reaching policies, programs and partnerships.
For more information, visit www.merck.ca.

SOURCE MERCK CANADA INC.


Source: PR Newswire